The economics of climate-sensitive infectious diseases affecting human health in Latin America and the Caribbean: a scoping review.

Clicks: 59
ID: 281690
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #37 of 37 articles by views in BMJ global health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The incidence of climate-sensitive infectious diseases (CSIDs), such as dengue, chikungunya and Zika, has been rising in Latin America and the Caribbean (LAC). Reported cases of these diseases nearly doubled between 2022 and 2023, with the highest figure reported from Brazil. However, evidence regarding the economic cost of CSIDs is limited in the region. This scoping review aims to identify the available evidence on the economic impacts of CSIDs in LAC countries and the potential costs and benefits of adaptation interventions. We searched PubMed, the Virtual Health Library, Web of Science, Scopus, JSTOR and EconPapers and included peer-reviewed and grey-literature studies published between January 2015 and December 2023. 10 peer-reviewed studies were included in this review: 9 assessed the economic impacts of the health consequences of CSIDs and 1 assessed the economics of adaptation policies or programmes concerning human health in LAC countries. Most studies were conducted in Mexico and Brazil. Studies have focused primarily on the economic costs of arboviruses, influenza and enteritis. The outcomes most frequently studied were disability-adjusted life years and mortality. Only one study evaluated the economic impact of implementing an adaptation intervention for dengue. These findings highlight a significant gap in understanding the economic impacts of CSIDs, particularly because most studies fail to monetise the reported metrics, limiting their ability to provide a comprehensive assessment of economic costs and cost-effectiveness analyses of interventions. There is a need for further research in this field, incorporating data from a diverse range of countries in the region and analysing the economic impacts of various CSIDs, as well as the cost-effectiveness of interventions aimed at reducing their prevalence.
Reference Key
caballero2025the Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Caballero, Nohemi; González-Teshima, Laura Yuriko; Arias-Amaya, Juan Sebastian; Castaño-Duque, Sebastian; González-Uribe, Catalina; González, Camila; Sarmiento, Juliana Helo; Niño-Machado, Natalia; Pinilla-Roncancio, Mónica
Journal BMJ global health
Year 2025
DOI
10.1136/bmjgh-2024-018302
URL
Keywords
Epidemiology review infections, diseases, disorders, injuries

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.